StockData
Elevance Health, Inc. logo

Elevance Health, Inc.

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3014% below fair value
$413.60−6.47 (-1.54%)

Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –

Elevance Health Board-Approved Share Repurchase Authorization Remaining by Year

Board-Approved Share Repurchase Authorization Remaining ($M)

Elevance Health Board-Approved Share Repurchase Authorization Remaining: $6,695M in FY2025, down 28.0% from a year earlier.

Latest, FY2025
6,695
Period ended Dec 31, 2025
Change on a year earlier
-28.0%
9,300 in FY2024
History
12 years
Since FY2014
Sources
2
Documents cited below

Where the FY2025 figure comes from

“us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 (2025-12-31): 6,695,000,000.00”

Source: ELV 10-K (XBRL us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1) ↗

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). Elevance Health Board-Approved Share Repurchase Authorization Remaining ($M), annual FY2014–FY2025 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/buyback-authorization-remaining

See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.